Product Information
FEBUXOSTAT 40 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.2114 per EA under NDC 33342027407. Its NADAC has been published 121 times since May 1, 2024.
FDA first approved this application on Sep 28, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342027407
Classification
Generic
Dosage Form
FILM
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
FEBUXOSTATApproval Type
Generic (ANDA)
FDA Application
ANDA207293FDA Approved
9/28/2023
TE Code
AB
On Market Since
4/4/2019
Pharmacological Classes
Price Statistics
The NADAC for FEBUXOSTAT 40 MG TABLET has been published 121 times since May 1, 2024, and over the history we have for it it has declined 41.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2114 per EA |
|---|---|
| All-time high | $0.4213 (Jul 10, 2024) |
| All-time low | $0.2016 (Jan 21, 2026) |
| 52-week high | $0.2818 |
| 52-week low | $0.2016 |
| Median price | $0.3238 |
| Average price | $0.2980 |
| Largest weekly change | -23.1% (Jul 17, 2024) |
| Weeks tracked | 121 |
| Tracking since | May 1, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Febuxostat tablets 40 mg market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FEBUXOSTAT 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FEBUXOSTAT 40 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.2114 per EA (NDC 33342027407), effective Aug 19, 2026.
How has the price of FEBUXOSTAT 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for FEBUXOSTAT 40 MG TABLET has declined 41.0%. It has been tracked across 121 weekly CMS publications since May 1, 2024.
What are the highest and lowest recorded NADAC prices for FEBUXOSTAT 40 MG TABLET?
Since May 1, 2024, the NADAC for FEBUXOSTAT 40 MG TABLET has ranged from a low of $0.2016 (Jan 21, 2026) to a high of $0.4213 (Jul 10, 2024), with a median of $0.3238 per EA.
Are there cheaper alternatives to FEBUXOSTAT 40 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of FEBUXOSTAT 40 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FEBUXOSTAT 40 MG TABLET?
FEBUXOSTAT 40 MG TABLET (NDC 33342027407) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.